TScan Therapeutics TCRX
NASDAQ TCRX
$0.20 -0.01 (-6.01%)
At close: Oct 23, 2026 · 4:00 PM EDT

TScan Therapeutics (TCRX) Other financing activities (2021 - 2025)

Updated

TScan Therapeutics (TCRX) recorded Other financing activities of $200,000 in FY2025.

Analysis

TScan Therapeutics (TCRX) Other financing activities (2021 - 2025) Analysis & Trends

  • Annual Other financing activities has a three-year compound annual growth rate of -14.9% (FY2022 to FY2025).
  • The FY2025 figure is the highest annual Other financing activities since FY2022.
  • Per Business Quant data, TCRX's Other financing activities was $324,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 TScan Therapeutics 26.76 Mn -538.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -75,000.00
Mar 31, 2025 -125,000.00
Dec 31, 2022 -94,000.00
Sep 30, 2022 -230,000.00
Sep 30, 2021 960,000.00
Jun 30, 2021 -748,000.00
Mar 31, 2021 -212,000.00
API Access

TScan Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=TCRX&period=max&api_key=YOUR_API_KEY